These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8099541)

  • 41. Fatal hypersensitivity reaction to sulphasalazine.
    Pears JS; Morley KD
    Br J Rheumatol; 1989 Jun; 28(3):274-5. PubMed ID: 2567194
    [No Abstract]   [Full Text] [Related]  

  • 42. [Salazopyrine desensitization].
    Schydlowsky P
    Ugeskr Laeger; 1993 Feb; 155(7):476-8. PubMed ID: 8096664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapy of seronegative oligoarthritis with salazopyrine].
    Stroehmann I; Wüstenhagen E; Martini M
    Z Rheumatol; 1987; 46(2):79-82. PubMed ID: 2885989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe immunological reaction induced by sulphasalazine.
    Pettersson T; Gripenberg M; Molander G; Friman C
    Br J Rheumatol; 1990 Jun; 29(3):239-40. PubMed ID: 1972635
    [No Abstract]   [Full Text] [Related]  

  • 45. Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial.
    van der Heijde D; Braun J; Dougados M; Sieper J; Pedersen R; Szumski A; Koenig AS
    Rheumatology (Oxford); 2012 Oct; 51(10):1894-905. PubMed ID: 22772319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulphasalazine in arthritis--an old drug rediscovered.
    Taggart AJ
    Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sulphasalazine-induced DRESS.
    Teo L; Tan E
    Singapore Med J; 2006 Mar; 47(3):237-9. PubMed ID: 16518561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sulphasalazine-induced systemic lupus erythematous in a patient with ankylosing spondylitis.
    Tsai WC; Chen CJ; Yen JH; Liu HW
    Clin Rheumatol; 2002 Aug; 21(4):339-40. PubMed ID: 12296286
    [No Abstract]   [Full Text] [Related]  

  • 49. Haematological side-effects of sulphasalazine in inflammatory arthritis.
    Hopkinson ND; Saiz Garcia F; Gumpel JM
    Br J Rheumatol; 1989 Oct; 28(5):414-7. PubMed ID: 2571387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulphasalazine-induced lupus in psoriatic arthritis.
    Veale DJ; Ho M; Morley KD
    Br J Rheumatol; 1995 Apr; 34(4):383-4. PubMed ID: 7788157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulphasalazine in rheumatoid arthritis.
    Boey ML; Lee E; Feng PH
    Singapore Med J; 1988 Jun; 29(3):285-8. PubMed ID: 2903555
    [No Abstract]   [Full Text] [Related]  

  • 52. Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study.
    Donovan S; Hawley S; MacCarthy J; Scott DL
    Br J Rheumatol; 1990 Jun; 29(3):201-4. PubMed ID: 1972633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sulphasalazine-related life-threatening side effects: is N-acetylcysteine of therapeutic value?
    Gabay C; De Bandt M; Palazzo E
    Clin Exp Rheumatol; 1993; 11(4):417-20. PubMed ID: 8104747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.
    Can M; Aydın SZ; Niğdelioğlu A; Atagündüz P; Direskeneli H
    Int J Rheum Dis; 2012 Dec; 15(6):526-30. PubMed ID: 23253235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Desensitization to sulfonamides in patients with HIV infection.
    Torgovnick J; Arsura E
    Am J Med; 1990 May; 88(5):548-9. PubMed ID: 2140014
    [No Abstract]   [Full Text] [Related]  

  • 56. The three week sulphasalazine syndrome.
    Brooks H; Taylor HG; Nichol FE
    Clin Rheumatol; 1992 Dec; 11(4):566-8. PubMed ID: 1362531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of sulphasalazine in the treatment of spondyloarthropathies.
    Dougados M; Maetzel A; Mijiyawa M; Amor B
    Ann Rheum Dis; 1992 Aug; 51(8):955-8. PubMed ID: 1358038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Life-threatening liver failure and severe dyscrasias in blood and lymph nodes caused by sulphasalazine].
    Kampmann P; Højlyng N; Pedersen M
    Ugeskr Laeger; 2006 Sep; 168(39):3331-3. PubMed ID: 17032600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seizures and hepatotoxicity following sulphasalazine administration.
    Sentürk T; Aydintuğ AO; Düzgün N; Tokgöz G
    Rheumatol Int; 1997; 17(2):75-7. PubMed ID: 9266624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fixed eruption to sulphasalazine.
    Kanwar AJ; Singh M; Yunus M; Belhaj MS
    Dermatologica; 1987; 174(2):104. PubMed ID: 2881814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.